Merck
MRK
#63
Rank
โ‚ฌ208.76 B
Marketcap
83,58ย โ‚ฌ
Share price
0.52%
Change (1 day)
-12.71%
Change (1 year)

Merck (MRK) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ15.63 Billion

According to Merck's latest financial reports the company has โ‚ฌ15.63 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Merck - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ13.15 B105.02%
2023-12-31โ‚ฌ6.41 B-47.83%
2022-12-31โ‚ฌ12.29 B72.03%
2021-12-31โ‚ฌ7.14 B9.23%
2020-12-31โ‚ฌ6.54 B-29.84%
2019-12-31โ‚ฌ9.32 B20.39%
2018-12-31โ‚ฌ7.74 B9.4%
2017-12-31โ‚ฌ7.08 B-48.05%
2016-12-31โ‚ฌ13.63 B11.03%
2015-12-31โ‚ฌ12.28 B-4.99%
2014-12-31โ‚ฌ12.92 B2.08%
2013-12-31โ‚ฌ12.66 B3.76%
2012-12-31โ‚ฌ12.20 B5.84%
2011-12-31โ‚ฌ11.52 B25.69%
2010-12-31โ‚ฌ9.17 B36.84%
2009-12-31โ‚ฌ6.70 B70.81%
2008-12-31โ‚ฌ3.92 B-30.38%
2007-12-31โ‚ฌ5.63 B-14.63%
2006-12-31โ‚ฌ6.60 B-49.98%
2005-12-31โ‚ฌ13.20 B152.57%
2004-12-31โ‚ฌ5.22 B57.69%
2003-12-31โ‚ฌ3.31 B-30.3%
2002-12-31โ‚ฌ4.75 B27.79%
2001-12-31โ‚ฌ3.72 B-17.6%
2000-12-31โ‚ฌ4.51 B41.91%
1999-12-31โ‚ฌ3.18 B44.9%
1998-12-31โ‚ฌ2.19 B131.64%
1997-12-31โ‚ฌ0.94 B-16.81%
1996-12-31โ‚ฌ1.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
โ‚ฌ12.85 B-17.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ15.92 B 1.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ8.50 B-45.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.16 B-9.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ8.96 B-42.62%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚ฌ3.81 B-75.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.89 B-87.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
โ‚ฌ8.37 B-46.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
โ‚ฌ6.63 B-57.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.10 B-48.14%๐Ÿ‡บ๐Ÿ‡ธ USA